Literature DB >> 8208669

Placental water content and distribution.

G Barker1, R D Boyd, S W D'Souza, P Donnai, H Fox, C P Sibley.   

Abstract

The percentage of total placental water (%H2O(T)), maternal (%MBV) and fetal (%FBV) blood volumes, non-vascular extracellular (%EW) and intracellular (%IW) water, and villous histology were studied in placentas from 12 normal term pregnancies after a normal vaginal delivery, 19 caesarean sections at term after a normal pregnancy and history of a previous caesarean section and 47 caesarean sections at term or preterm due to pregnancy complications. Values were derived from change in placental dry weight, maternal and fetal haemoglobin content and 51CrEDTA space after incubation of placental fragments. Normal ranges (mean +/- SD) after term vaginal delivery were: H2O(T) 83.9 +/- 0.2%, MBV 10.9 +/- 0.2%, FBV 7.4 +/- 0.9%, EW 57.3 +/- 1.3% and IW 11.2 +/- 0.6%. %H2O(T) was higher after caesarean section; other measurements were not affected. There were no differences between placentas after 33-37 and after 38-42 weeks gestation. Three of eight placentas after rhesus incompatibility had %H2O(T) above the mean +2SD of term placentas and five of 17 IUGR placentas were below the mean -2SD. The remaining placentas following maternal pre-eclampsia, hypertension, or diabetes had no apparent alteration in %H2O(T). A blind histological diagnosis of 'true' oedema was associated with both a significantly high %IW and %H2O(T). Perhaps this is due to alteration in placental cell volume regulation in certain situations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208669     DOI: 10.1016/s0143-4004(05)80235-8

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  4 in total

1.  A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome).

Authors:  Jimmy Espinoza; Roberto Romero; Jyh Kae Nien; Juan Pedro Kusanovic; Karina Richani; Ricardo Gomez; Chong Jai Kim; Pooja Mittal; Francesca Gotsh; Offer Erez; Tinnakorn Chaiworapongsa; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2006-10

2.  Patterns of adiponectin expression in term pregnancy: impact of obesity.

Authors:  Maricela Haghiac; Subhabrata Basu; Larraine Presley; David Serre; Patrick M Catalano; Sylvie Hauguel-de Mouzon
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

3.  Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.

Authors:  Khaled Abduljalil; Amita Pansari; Jia Ning; Masoud Jamei
Journal:  Clin Pharmacokinet       Date:  2022-01-24       Impact factor: 6.447

4.  Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the Ex Vivo Perfused Placenta.

Authors:  Gaby A M Eliesen; Joris van Drongelen; Hedwig van Hove; Nina I Kooijman; Petra van den Broek; Annick de Vries; Nel Roeleveld; Frans G M Russel; Rick Greupink
Journal:  Clin Pharmacol Ther       Date:  2020-04-08       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.